These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 19446189

  • 1. Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice.
    Oma K, Zhao J, Ezoe H, Akeda Y, Koyama S, Ishii KJ, Kataoka K, Oishi K.
    Vaccine; 2009 May 21; 27(24):3181-8. PubMed ID: 19446189
    [Abstract] [Full Text] [Related]

  • 2. Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice.
    Ezoe H, Akeda Y, Piao Z, Aoshi T, Koyama S, Tanimoto T, Ishii KJ, Oishi K.
    Vaccine; 2011 Feb 17; 29(9):1754-61. PubMed ID: 21219977
    [Abstract] [Full Text] [Related]

  • 3. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.
    Vaccine; 2011 Aug 05; 29(34):5731-9. PubMed ID: 21696869
    [Abstract] [Full Text] [Related]

  • 4. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
    Ferreira DM, Oliveira ML, Moreno AT, Ho PL, Briles DE, Miyaji EN.
    Microb Pathog; 2010 Jun 05; 48(6):205-13. PubMed ID: 20206678
    [Abstract] [Full Text] [Related]

  • 5. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.
    Yamamoto M, Briles DE, Yamamoto S, Ohmura M, Kiyono H, McGhee JR.
    J Immunol; 1998 Oct 15; 161(8):4115-21. PubMed ID: 9780183
    [Abstract] [Full Text] [Related]

  • 6. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
    Shah P, Briles DE, King J, Hale Y, Swiatlo E.
    Exp Biol Med (Maywood); 2009 Apr 15; 234(4):403-9. PubMed ID: 19176871
    [Abstract] [Full Text] [Related]

  • 7. Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae.
    Fukuyama Y, King JD, Kataoka K, Kobayashi R, Gilbert RS, Oishi K, Hollingshead SK, Briles DE, Fujihashi K.
    J Immunol; 2010 Aug 01; 185(3):1755-62. PubMed ID: 20585031
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
    Coats MT, Benjamin WH, Hollingshead SK, Briles DE.
    Vaccine; 2005 Jul 21; 23(33):4257-62. PubMed ID: 16005736
    [Abstract] [Full Text] [Related]

  • 9. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT, Xu Q, Paton JC, Hollingshead SK, Pichichero ME, Briles DE, Girgis N, Zeng M.
    FEMS Immunol Med Microbiol; 2009 Apr 21; 55(3):346-51. PubMed ID: 19291171
    [Abstract] [Full Text] [Related]

  • 10. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B, Chen X, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Wu Y.
    Microb Pathog; 2018 Oct 21; 123():115-119. PubMed ID: 29959043
    [Abstract] [Full Text] [Related]

  • 11. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, Shan Y, Yin Y.
    Vaccine; 2007 Jun 28; 25(27):4996-5005. PubMed ID: 17524530
    [Abstract] [Full Text] [Related]

  • 12. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J, Medina M, Racedo S, Alvarez S.
    J Microbiol Immunol Infect; 2010 Feb 28; 43(1):1-10. PubMed ID: 20434117
    [Abstract] [Full Text] [Related]

  • 13. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L, Jeurissen A, Mittler RS, Wuyts G, Michiels G, Boon L, Ceuppens JL, Bossuyt X.
    J Leukoc Biol; 2007 Sep 28; 82(3):638-44. PubMed ID: 17550973
    [Abstract] [Full Text] [Related]

  • 14. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.
    Richards L, Ferreira DM, Miyaji EN, Andrew PW, Kadioglu A.
    Immunobiology; 2010 Apr 28; 215(4):251-63. PubMed ID: 20071053
    [Abstract] [Full Text] [Related]

  • 15. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
    Briles DE, Hollingshead SK, King J, Swift A, Braun PA, Park MK, Ferguson LM, Nahm MH, Nabors GS.
    J Infect Dis; 2000 Dec 28; 182(6):1694-701. PubMed ID: 11069242
    [Abstract] [Full Text] [Related]

  • 16. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 28; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 17. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
    Ferreira DM, Darrieux M, Oliveira ML, Leite LC, Miyaji EN.
    Clin Vaccine Immunol; 2008 Mar 28; 15(3):499-505. PubMed ID: 18184825
    [Abstract] [Full Text] [Related]

  • 18. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.
    Hedhli D, Dimier-Poisson I, Judge JW, Rosenberg B, Mévélec MN.
    Vaccine; 2009 Apr 06; 27(16):2274-81. PubMed ID: 19428842
    [Abstract] [Full Text] [Related]

  • 19. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M, Ikeda Y, Suzumoto M, Yamauchi K, Green BA, Zlotnick G, Billal DS, Shimada J, Fujihara K, Yamanaka N.
    Vaccine; 2005 Jan 26; 23(10):1294-300. PubMed ID: 15652672
    [Abstract] [Full Text] [Related]

  • 20. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC, Bosarge JR, Quin LR, McDaniel LS.
    Vaccine; 2006 Jul 17; 24(29-30):5755-61. PubMed ID: 16759765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.